Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
(Q29620647)
scientific article (publication date: 20 October 2011)
scientific article (publication date: 20 October 2011)
Language:
Current Data About
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study